Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

IBIO Stock Forecast, Price Targets, Chart, Dividends & Analysis

iBio Inc. logo

iBio Inc.

Sector: Healthcare   

Industry: Biotechnology

2.60
 
USD
  
-0.20
  
(-7.14%)
Previous close: 2.8  Open: 2.77  Bid: 2.6  Ask: 2.75
52 week range    
1.02   
   4.98
Mkt Cap: 23 M  Avg Vol (90 Days): 136,124
Peers   
GNCA / 
EBS / 
JNJ / 
Last updated: Wednesday 4th December 2024

Stock Rankings

61
Technical
21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

EBS

1 B-19.29

GNCA

0.0006

JNJ

0.032372 B26.14152.36

NKTR

0 B-11.07
Financials

IBIO Income Statement

Annual
Jun-14Jun-15Jun-16Jun-17Jun-18Jun-19Jun-20Jun-21Jun-22Jun-23
AccruedPreferredStockDividends90000.0260000.0260000.022 M260000.088000.0
Amortization of intangibles-358000.0-358000.0-363000.0-350000.0-341000.0-322000.01 M952000.05 M5 M
Basic EPS from continuing operations-0.61-3.0-9.17-7.7
Basic EPS total-0.61-3.0-11.56-10.62
Basic weighted shares outstanding3 M3 M3 M4 M425240.0757040.063 M8 M9 M12 M
BasicDiscontinuousOperations-2.39-2.92
Cost of sales703000.01 M216000.0
Depreciation-5000.0-577000.0-1 M-1 M-1 M282000.0472000.02 M273000.0
Depreciation unreconciled-179000.0
DepreciationAndAmortization-5000.0-577000.0-1 M-1 M-179000.0282000.0472000.02 M273000.0
DevelopmentExpense-1 M
Diluted EPS total-1.5-2.25-3.0-4.0-38.5-23.5-0.61-3.0-11.56-10.62
Diluted normalized net income/share-23.5-3.0-9.17-7.7
Diluted weighted shares outstanding2 M3 M3 M4 M418311.0757040.063 M8 M9 M12 M
DilutedDiscontinuousOperations-2.39-2.92
ExciseTaxes-1 M
GainOnSaleOfPPE-1000.0-48000.0-33000.0
GainOnSaleOfSecurity-98000.0
GainsLossOnDisposalOfDiscontinuedOperations283000.0339000.0
GeneralAndAdministrativeExpense3 M5 M8 M11 M11 M12 M11 M22 M22 M19 M
Gross operating profit1 M2 M948000.0394000.0444000.02 M935000.0909000.02 M
ImpairmentOfCapitalAssets18 M
Income before tax-4 M-7 M-11 M-16 M-16 M-18 M-16 M-23 M-30 M-29 M
Income taxes-3 M-2 M-55000.0-9 M-12 M
Interest income8000.09000.022000.039000.015000.075000.015000.0140000.0177000.0213000.0
InterestExpenseNonOperating807000.02 M2 M2 M2 M2 M1 M83000.0
InterestExpenseOperating-122000.0-807000.0-2 M-2 M-2 M
MinorityInterests893000.02 M3000.04000.05000.06000.01000.015 M
MiscOtherSpecialCharges3000.044000.01 M10000.012000.07000.0100.0
Net income from total operations-4 M-7 M-10 M-15 M-16 M-18 M-16 M-23 M-50 M-65 M
NetIncomeCommonStockholders-4 M-7 M-10 M-15 M-16 M-18 M-38 M-23 M-101 M-65 M
NetIncomeContinuousOperations-4 M-7 M-10 M-15 M-16 M-18 M-16 M-23 M-50 M-65 M
NetIncomeDiscontinuousOperations-21 M-36 M
NetIncomeExtraordinary-50 M-65 M
NetNonOperatingInterestIncomeExpense8000.09000.0-785000.0-2 M-2 M-2 M-2 M-2 M177000.0130000.0
NonRecurringOperationExpense-1 M-10 M
Normalized income-33 M-23 M
Operating income-4 M-7 M-10 M-14 M-14 M-16 M-14 M-31 M-30 M-29 M
Operating income before depreciation (EBITDA)-3 M-6 M-10 M-14 M-14 M-16 M-12 M-18 M-26 M-28 M
OperatingExpense-4 M-9 M-11 M-15 M-15 M18 M15 M32 M32 M29 M
Other income net-2000.048000.033000.0-44000.0-1 M-10000.0-12000.0-7000.098000.0
Other special charges-42000.0-32000.0-21000.0-25000.0-19000.0-16000.0
OtherGainLossFromDispositionOfDiscontinuedOperations-21 M-36 M
OtherGandA3 M5 M8 M11 M11 M12 M11 M22 M22 M19 M
OtherImpairmentOfCapitalAssets2 M565000.0
OtherOperatingExpenses-2 M-877000.0-18 M15 M4 M1 M563000.0
OtherunderPreferredStockDividend90000.0260000.0260000.022 M260000.088000.0
PreferredStockDividends90000.0260000.0260000.022 M260000.088000.0
RentAndLandingFees4 M5 M8 M11 M11 M-2 M
Research & development expense857000.03 M3 M4 M4 M5 M4 M10 M10 M10 M
ResearchExpense2 M3 M3 M4 M4 M5 M4 M10 M10 M10 M
Revenue per share-358000.0-358000.0-363000.0-350000.0-341000.0-322000.03 M3 M5 M6 M
SalariesAndWages-1 M-914000.0-1 M-1 M-770000.0-874310.0
SecuritiesAmortization1 M
Selling Gen & administrative expense3 M5 M8 M11 M11 M12 M11 M22 M22 M19 M
SellingAndMarketingExpense-942000.0-1 M1 M2 M
Special income/charges42000.032000.021000.025000.019000.016000.010 M-18 M
Total Income available for interest expense (EBIT)-4 M-7 M-11 M-16 M-16 M-18 M-14 M-21 M-30 M-29 M
Total common shares outstanding269841.0309301.0356437.0371274.0733471.048304.0360575.0435746.0450329.028 M
Total net income-4 M-7 M-10 M-15 M-16 M-18 M-16 M-23 M-50 M-65 M
Total ordinary shares9 M9 M9 M9 M9 M9 M9 M9 M9 M9 M
Total revenues205000.02 M948000.0394000.0444000.02 M2 M2 M2 M
TotalExpenses-4 M-9 M-11 M-15 M-15 M18 M16 M33 M32 M29 M
TotalRevenue205000.02 M948000.0394000.0444000.02 M2 M2 M2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University